FDA Approval: ANZUPGO (DELGOCITINIB) — Type 1 - New Molecular Entity
Dermatology
CPT procedure code
88230 — Tissue culture for neoplastic disorders, lymphocyte
PathologyCPT
Code definition
Code
88230
Code system
CPT (Current Procedural Terminology)
Description
Tissue culture for neoplastic disorders, lymphocyte
Category
Pathology
Short description sourced from CMS publicly available fee schedule data. Full CPT descriptions are copyright AMA. Not a substitute for the official CPT codebook.
Latest reimbursement alerts
No alerts currently reference 88230 directly. Here are the latest policy changes across all codes.
Low
FDA Approval: LEQSELVI (DEURUXOLITINIB PHOSPHATE) — Type 1 - New Molecular Entity
Dermatology
FDA Approval: ONAPGO (APOMORPHINE HYDROCHLORIDE) — Type 5 - New Formulation or New Manufacturer
Neurology
Medicare Coverage Database - New Items
General
CMS Physician Fee Schedule
Physician Fee Schedule
CMS MAC Archives
General
Related CPT codes (882xx)
88233PathologyTissue culture for neoplastic disorders, skin/tissue biopsy
88237PathologyTissue culture for neoplastic disorders, bone marrow/blood
88262PathologyChromosome analysis; 15-20 cells, 2 karyotypes
88271PathologyMolecular cytogenetics; DNA probe, each
88280PathologyChromosome analysis; additional karyotypes, each study
Get alerts when policy changes affect 88230
Free weekly digest — no subscription required.
Look up another code
Search ICD-10, HCPCS, or CPT codes with related reimbursement alerts.